This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Endoscopic mucosal resection (EMR) is a minimally invasive procedure used to remove lesions from the gastrointestinal (GI) tract. It is a safe and effective way to remove precancerous and cancerous lesions from within the GI tract, as well as other types of lesions such as polyps. The procedure can be performed in the outpatient setting and is typically conducted using an endoscope, which is a flexible tube with a camera attached. During EMR, the doctor will first use the endoscope to locate and identify the lesion. A small amount of saline solution will then be injected into the area to raise the lesion, which makes it easier to remove. The doctor will then use a specialized piece of equipment to cut the lesion away from the wall of the GI tract. This piece of equipment is known as an endoscopic mucosal resection. After the lesion is removed, the doctor will use the endoscope to examine the area to make sure it is free of any remaining tissue. EMR is considered to be a safe and effective procedure for removing precancerous and cancerous lesions. It does not require major surgery and has a high success rate in treating precancerous and cancerous lesions. In addition, it can be used to treat a variety of other lesions, including polyps. EMR is an important tool for early detection and prevention of lesions in the GI tract. By catching the lesions early, it can help to reduce the risk of complications and progression of the disease. It is also a valuable tool in the treatment of precancerous and cancerous lesions, as it can help to prevent them from becoming more serious.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States